ADEPT - Abnormal Doppler Enteral Prescription Trial

ISRCTN ISRCTN87351483
DOI https://doi.org/10.1186/ISRCTN87351483
Secondary identifying numbers SP4006
Submission date
30/09/2004
Registration date
30/09/2004
Last edited
14/02/2014
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Neonatal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Study website

Contact information

Dr Alison Leaf
Scientific

Consultant Neonatologist
Southmead Hospital
Bristol
BS10 5NB
United Kingdom

Phone +44 (0)117 9596141
Email alison.leaf@nbt.nhs.uk

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleRandomised controlled trial of early versus late initiation of milk feeds for infants with absent or reversed end diastolic flow velocities (AREDFV) or cerebral redistribution
Study acronymADEPT
Study objectivesThe aim is to evaluate the effects of an 'early' enteral feeding regimen, starting milk feeds on day 2 after birth (between 24 and 48 hours of age) compared to one of 'late' introduction of enteral feeds, starting feeds on day 6 after birth (between 120 - 144 hours of age) in a group of babies identified as being at high risk for necrotising enterocolitis (NEC) and milk intolerance by antenatal Doppler studies.

Added 23/11/2007:
Please note that due to an extension in funding from Action Medical Research the anticipated end date of this trial has been extended to 31/12/2008. The previous end date of this trial was 05/03/2008.
Ethics approval(s)Oxfordshire Research Ethics Committee (REC) C gave approval on the 27th September 2005 (ref: 05/Q1606/121)
Health condition(s) or problem(s) studiedNutrition
InterventionFeeding of preterm infants after absent or reversed end-diastolic flow velocities (AREDFV). Babies will be randomly allocated to an 'early' or 'late' enteral feeding regimen. These will start milk feeds on day 2 and day 6 after birth, respectively.
Intervention typeOther
Primary outcome measure1. Age in days at which full enteral feeding sustained for 72 hours was reached
2. Necrotising enterocolitis, stage I, II or III
Secondary outcome measures1. Death before hospital discharge
2. Duration of hospital stay
3. Duration of intensive and high dependency care
4. Duration of parenteral nutrition
5. Change in Z score for weight and head circumference from birth to 36 weeks postmenstrual age and from birth to discharge
6. In continuous supplemental oxygen at 36 weeks post-menstrual age
7. Confirmed bacterial sepsis
8. Gastrointestinal perforation
9. Gastrointestinal surgery
10. Cholestasis (defined as greater than 25 μmol/l conjugated fraction of serum bilirubin)
11. Patent ductus arteriosus requiring pharmacological or surgical treatment
12. Type of milk at discharge
13. On oxygen therapy at discharge

This information is collected prior to the baby being discharged home.
Overall study start date01/09/2005
Completion date31/12/2008

Eligibility

Participant type(s)Patient
Age groupNeonate
SexBoth
Target number of participants400 babies
Key inclusion criteriaInfants admitted to participating neonatal units and satisfying all of the following criteria may be recruited into the study:
1. Gestational age up to and including 34 weeks + 6 days
2. Antenatal ultrasound showing either:
2.1. Absent or reversed end diastolic flow velocities on at least 50% of the Doppler waveforms from the umbilical artery on at least one occasion during pregnancy, or
2.2. Cerebral redistribution, defined as occurring when both the umbilical artery pulsatility index is greater than the 95th centile and the middle cerebral artery pulsatility index is less that the 5th centile for gestational age
3. Small for gestational age
4. Postnatal age 20 - 48 hours
Key exclusion criteriaInfants will be excluded if any of the following factors are present:
1. Major congenital abnormality including known chromosomal abnormality
2. Twin-twin transfusion
3. Intra-uterine transfusion or exchange transfusion
4. Rhesus iso-immunisation
5. Significant multi-organ failure prior to trial entry
6. Inotropic drug support prior to trial entry
7. Already received any enteral feeding
Date of first enrolment01/09/2005
Date of final enrolment31/12/2008

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Consultant Neonatologist
Bristol
BS10 5NB
United Kingdom

Sponsor information

University of Oxford (UK)
University/education

University Offices
Wellington Square
Oxford
OX1 2JD
England
United Kingdom

Phone +44 (0)1865 270000
Email research.services@admin.ox.ac.uk
Website http://www.ox.ac.uk
ROR logo "ROR" https://ror.org/052gg0110

Funders

Funder type

Charity

Action Medical Research (UK)
Private sector organisation / Trusts, charities, foundations (both public and private)
Alternative name(s)
actionmedres, action medical research for children, AMR
Location
United Kingdom

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article protocol 02/10/2009 Yes No
Results article results 01/05/2012 Yes No
Results article results 01/01/2014 Yes No